These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1053 related items for PubMed ID: 18471782

  • 1. Intra-prostatic androgen levels during various androgen-blockade regimens.
    Nishiyama T.
    Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):229-41. PubMed ID: 18471782
    [Abstract] [Full Text] [Related]

  • 2. Hormonal therapy of prostate cancer.
    Labrie F.
    Prog Brain Res; 2010 Apr; 182():321-41. PubMed ID: 20541672
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The influence of androgen deprivation therapy on dihydrotestosterone levels in the prostatic tissue of patients with prostate cancer.
    Nishiyama T, Hashimoto Y, Takahashi K.
    Clin Cancer Res; 2004 Nov 01; 10(21):7121-6. PubMed ID: 15534082
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Endocrine therapy for prostate cancer.
    Damber JE.
    Acta Oncol; 2005 Nov 01; 44(6):605-9. PubMed ID: 16165920
    [Abstract] [Full Text] [Related]

  • 11. Endocrine therapy: where do we stand and where are we going?
    Schröder FH.
    Cancer Surv; 1991 Nov 01; 11():177-94. PubMed ID: 1841751
    [Abstract] [Full Text] [Related]

  • 12. [Maximal androgen blockade in the treatment of patients with disseminated cancer of the prostate].
    Matveev BP, Bukharkin BV.
    Vopr Onkol; 1998 Nov 01; 44(5):537-40. PubMed ID: 9884710
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Controversies in the management of advanced prostate cancer.
    Tyrrell CJ.
    Br J Cancer; 1999 Jan 01; 79(1):146-55. PubMed ID: 10408706
    [Abstract] [Full Text] [Related]

  • 20. Biologic agents as adjunctive therapy for prostate cancer: a rationale for use with androgen deprivation.
    Nelson EC, Cambio AJ, Yang JC, Lara PN, Evans CP.
    Nat Clin Pract Urol; 2007 Feb 01; 4(2):82-94. PubMed ID: 17287869
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.